GlassScriptPhysician profile
Victor Priego
NPI 1003875295
$41,577.44
in general payments reported to CMS, 2019-2025
100 companies · $4,769 in 2025
The $4,769 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,425 · 2021: $5,324 · 2022: $7,656 · 2023: $5,317 · 2024: $4,952 · 2025: $4,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,883.53 |
| Education | $154.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $6,512.70 | 2019-2025 | |
| Celgene Corporation | $3,765.38 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Jazz Pharmaceuticals INC. | $3,185.55 | 2019-2022 | |
| Janssen Biotech, INC. | $2,101.84 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Pfizer INC. | $1,442.64 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,414.38 | 2019-2025 | Imfinzi, Calquence |
| E.R. Squibb & Sons, L.L.C. | $1,351.72 | 2019-2025 | Opdivo, Reblozyl, Augtyro |
| Merck Sharp & Dohme LLC | $1,158.51 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Genentech USA, INC. | $868.51 | 2019-2025 | Polivy, Lunsumio, Venclexta |
| Genzyme Corporation | $859.19 | 2019-2025 | |
| Secura Bio, INC. | $838.30 | 2020-2024 | Copiktra |
| Takeda Pharmaceuticals U.S.A., INC. | $774.22 | 2019-2025 | Hyqvia, Ninlaro, Cuvitru |
| Eisai INC. | $773.01 | 2019-2025 | |
| Incyte Corporation | $760.79 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Amgen INC. | $756.87 | 2019-2023 | Blincyto, Kyprolis, Tezspire |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $717.31 | 2019-2025 | Enhertu, Injectafer |
| Rigel Pharmaceuticals, INC. | $697.23 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Seagen INC. | $675.46 | 2019-2023 | Padcev, Tukysa, Tivdak |
| Astellas Pharma US INC | $498.65 | 2019-2025 | Padcev, Xtandi |
| Exelixis INC. | $486.69 | 2019-2025 | Cabometyx |
| Pharmaessentia USA Corporation | $476.31 | 2022-2025 | Besremi |
| Regeneron Healthcare Solutions, INC. | $455.62 | 2021-2025 | Libtayo, Lynozyfic |
| Pharmacyclics LLC, An Abbvie Company | $413.52 | 2019-2023 | Imbruvica, Epkinly |
| Bayer Healthcare Pharmaceuticals INC. | $408.49 | 2019-2025 | |
| Glaxosmithkline, LLC. | $389.20 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Lilly USA, LLC | $372.22 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Puma Biotechnology, INC. | $370.86 | 2019-2025 | |
| Abbvie INC. | $348.97 | 2020-2025 | |
| Sobi, INC | $326.44 | 2022-2025 | |
| Taiho Oncology, INC. | $321.73 | 2019-2025 | |
| Tempus Ai, INC | $306.24 | 2024-2025 | Xt Cdx |
| Emd Serono, INC. | $304.91 | 2019-2025 | Bavencio |
| Array Biopharma INC | $295.91 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Myriad Genetic Laboratories, INC. | $287.16 | 2020-2025 | Mychoice Cdx, Myrisk, Precisetumor |
| Sun Pharmaceutical Industries INC. | $272.70 | 2019-2025 | |
| Aveo Pharmaceuticals, INC. | $261.11 | 2021-2025 | Fotivda |
| Kite Pharma, INC. | $257.54 | 2020-2025 | Yescarta |
| Alexion Pharmaceuticals, INC. | $246.97 | 2019-2025 | Ultomiris |
| Gilead Sciences, INC. | $219.53 | 2019-2024 | Trodelvy |
| Beigene USA, INC. | $214.95 | 2020-2025 | Brukinsa, Tevimbra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.37 | 2019-2025 | |
| Global Blood Therapeutics, INC. | $209.36 | 2020-2022 | |
| Pharmacosmos Therapeutics INC. | $200.28 | 2020-2025 | Monoferric |
| Eusa Pharma (US) LLC | $174.57 | 2019-2022 | |
| Blueprint Medicines Corporation | $172.70 | 2020-2024 | Ayvakit |
| Tersera Therapeutics LLC | $166.32 | 2021-2025 | Zoladex, Xermelo |
| Myovant Sciences INC. | $164.49 | 2021-2022 | |
| Genmab U.S., INC. | $163.97 | 2023-2025 | Epkinly |
| Adc Therapeutics America, INC. | $162.73 | 2022-2025 | |
| Tg Therapeutics, INC. | $157.65 | 2021 | |
| Stemline Therapeutics INC. | $152.63 | 2021-2025 | Orserdu |
| Adaptive Biotechnologies Corporation | $143.60 | 2022-2024 | Clonoseq |
| Sumitomo Pharma America, INC. | $141.00 | 2024 | Orgovyx |
| Dendreon Pharmaceuticals LLC | $140.22 | 2020-2024 | Provenge |
| Mirati Therapeutics, INC. | $139.04 | 2023-2024 | Krazati |
| Servier Pharmaceuticals LLC | $135.67 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $132.19 | 2019-2025 | Xarelto |
| Morphosys, US INC. | $126.87 | 2021-2023 | Monjuvi |
| Azurity Pharmaceuticals, INC. | $122.61 | 2024-2025 | Danziten, Vivimusta, Nymalize |
| G1 Therapeutics, INC. | $114.84 | 2022-2023 | Cosela |
| Foundation Medicine, INC. | $114.79 | 2019-2023 | |
| Ipsen Biopharmaceuticals, INC | $114.55 | 2021-2024 | Somatuline Depot, Onivyde, Tazverik |
| Beone Medicines USA, INC. | $114.48 | 2025 | Brukinsa, Tevimbra |
| Coherus Oncology, INC. | $110.74 | 2022-2024 | |
| Advanced Accelerator Applications | $98.23 | 2019 | |
| Cti Biopharma Corp. | $89.20 | 2022 | |
| Kyowa Kirin, INC. | $82.48 | 2022-2024 | Poteligeo |
| Ge Healthcare | $81.57 | 2022 | |
| Heron Therapeutics, INC. | $79.35 | 2019-2022 | |
| Clovis Oncology, INC. | $78.11 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $76.77 | 2023-2025 | Givlaari |
| Deciphera Pharmaceuticals INC. | $76.11 | 2021-2025 | Qinlock, Romvimza |
| Fennec Pharmaceuticals, INC. | $72.79 | 2024-2025 | Fyarro, Pedmark |
| Acrotech Biopharma INC. | $72.61 | 2021-2025 | Beleodaq |
| Immunocore Limited | $71.05 | 2024-2025 | Kimmtrak |
| Spectrum Pharmaceuticals INC. | $63.73 | 2019-2025 | Rolvedon |
| Epizyme, INC. | $58.25 | 2020-2022 | |
| Caris Mpi, INC. | $56.89 | 2025 | Mi Cancer Seek |
| Syndax Pharmaceuticals, INC. | $55.92 | 2025 | |
| Karyopharm Therapeutics INC. | $52.38 | 2020-2023 | Xpovio |
| Tactile Systems Technology INC | $47.46 | 2024 | Entre Plus, Flexitouch Plus |
| Agios Pharmaceuticals, INC. | $46.24 | 2019-2020 | |
| Mylan Institutional INC. | $44.26 | 2019-2020 | |
| Tesaro, INC. | $42.79 | 2019 | |
| Iovance Biotherapeutics, INC. | $38.59 | 2025 | Amtagvi |
| Apellis Pharmaceuticals, INC. | $35.61 | 2022-2024 | Empaveli |
| Sirtex Medical INC | $34.64 | 2019 | |
| Acceleron Pharma, INC. | $33.97 | 2021 | |
| Partner Therapeutics, INC. | $29.64 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $29.33 | 2019-2022 | |
| Novocure INC. | $28.01 | 2025 | Optune Lua (Novottf-200t) |
| Geron Corporation | $27.00 | 2025 | Rytelo |
| Amneal Pharmaceuticals LLC | $24.78 | 2025 | Alymsys |
| Btg International INC. | $24.54 | 2022 | |
| Verastem, INC. | $22.20 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $19.92 | 2022 | |
| Sandoz INC. | $19.07 | 2020 | |
| Springworks Therapeutics, INC. | $19.01 | 2024 | Ogsiveo |
| Dova Pharmaceuticals | $15.55 | 2021 | |
| Cashflow Solutions, LLC | $14.47 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
Keytruda $519Enhertu $487Xtandi $427Besremi $424Darzalex $339Orgovyx $339Libtayo $328Kisqali $314Rezlidhia $303Tavalisse $303Opdivo $302Talzenna $284Epkinly $284Doptelet $283Tecvayli $280Rybrevant $275Reblozyl $265Padcev $259Imfinzi $254Fabhalta $242Jakafi $231Cabometyx $231Erleada $228Mychoice Cdx $209Monjuvi $209Venclexta $208Adcetris $204Imbruvica $201Pluvicto $199Lenvima $195Inlyta $189Elrexfio $185Ultomiris $183Fotivda $177Calquence $176Polivy $174Scemblix $166Mektovi $165Braftovi $165Ojjaara $165Brukinsa $155Tivdak $153Lorbrena $153Lunsumio $152Jaypirca $151Lonsurf $147Inqovi $147Krazati $139Orserdu $135Verzenio $131Clonoseq $130Sarclisa $128Yescarta $126Talvey $125Tukysa $121Pemazyre $119Lutathera $118Ibrance $117Carvykti $116Monoferric $115Retevmo $111Leqembi $105Lynparza $101Xofigo $101Nubeqa $101Jemperli $94.79Zejula $94.79Zynlonta $94.19Tabrecta $93.57Hyqvia $90.82Cosela $90.56Eliquis $86.10Xarelto $80.20Tevimbra $78.00Akeega $77.23Givlaari $76.77Welireg $75.74Pomalyst $74.15Bosulif $73.68Keytruda Qlex $72.28Piqray $71.15Kimmtrak $71.05Jevtana $70.57Ninlaro $69.40Udenyca $69.00Niktimvo $66.38Cuvitru $64.83Ayvakit $64.66Danziten $64.24Injectafer $63.93Beleodaq $60.03Alunbrig $59.45Zoladex $58.92Xt Cdx $58.67Mi Cancer Seek $56.89Fyarro $56.43Onivyde $55.95Somatuline Depot $55.95Promacta $55.28Cerdelga $54.75
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Priego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.